15 results
Glucose-lowering medication in type 2 diabetes - Algorithm

#Diabetes #Medications #Algorithm #Pharmacology #Pharmacotherapy #Hypoglycemic #Management #Endocrinology
Medications #Algorithm #Pharmacology ... Pharmacotherapy #Hypoglycemic ... #Management #Endocrinology
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
AntiPlatelet #Inhibitors #Pharmacology ... #Table #Overview ... #Interactions #Pharmacology ... #Cardiology
Warfarin color-coded tablets, initial dosing and INR targets

#pharmacology #overview #review #medications #drugs #cardiology #warfarin #management
INR targets #pharmacology ... #overview #review ... medications #drugs #cardiology
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... : Weight gain, Hypoglycemia ... Sulfonylureas #Pharmacology ... DM2 #diabetes #endocrinology
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
#Medications #Cardiology ... #Pharmacology # ... Therapy #Table #Overview
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
and compares the hypoglycemia ... #pharmacology #pharmacotherapy ... medications #diabetes #endocrinology
Pharmacologic treatment of hyperglycemia in adults with type 2 diabetes

#Diabetes #Management #Algorithm #endocrinology #pharmacology #medications
Pharmacologic treatment ... of hyperglycemia ... Management #Algorithm #endocrinology ... #pharmacology #
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Does not cause hypoglycemia ... #Metformin #Pharmacology ... DM2 #diabetes #endocrinology
Anastrozole is a Selective non-steroidal aromatase Inhibitor. Used for the treatment of breast cancer in postmenopausal
#pharmacology #overview ... druginformation #treatment #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
minimal chance of hypoglycemia ... Renal #Dosing #Pharmacology ... Diabetes #DM2 #Endocrinology